Clinical Oncology Development Webinar Today

The regulatory process can be confusing and difficult, especially for those who work in clinical drug development. Today, the FierceBiotech team brings you "Oncology Trials: Navigating the Regulatory Landscape." Hosted by our Editor-in-Chief John Carroll, this webinar will offer insights on best practices for managing the clinical drug development process and gaining approval. Panelists inlcude Scott Cormack, President and CEO of OncoGenex Technologies; Taylor Burtis, Vice President of Regulatory, Quality and Compliance, Tokai Pharmaceuticals; and Christoph Zanke, Global Strategic Head Oncology, AAIPharma.

If you're in clinical operations, this is a must-attend event. The webinar begins at 2p.m. EST. Don't miss it. Click here to sign up.  - Calisha

Suggested Articles

Post-Tesaro buyout, don’t expect GlaxoSmithKline to spring for more commercial-stage oncology products anytime soon.

Already a fast-growing blockbuster, Novo Nordisk's injectable Ozempic won a major heart-helping FDA nod that could bode well for its oral sibling.

Bayer's new Vitrakvi for tumors with NTRK gene fusions is meeting skepticism in England and Germany, where cost watchdogs on Friday rejected it.